BSE Live
Oct 17, 16:01Prev. Close
169.50
Open Price
169.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 17, 15:55Prev. Close
169.47
Open Price
168.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
167.10 (88)
Cash Flow of Nath Bio-Genes (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 13 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
Net Profit/Loss Before Extraordinary Items And Tax | 40.58 | 41.56 | 36.16 | -63.43 | 12.30 | |
Net CashFlow From Operating Activities | 17.58 | 74.59 | 38.37 | 17.05 | 14.21 | |
Net Cash Used In Investing Activities | -3.96 | -27.40 | -2.88 | -19.85 | -20.77 | |
Net Cash Used From Financing Activities | -2.13 | -7.78 | -1.67 | -22.23 | 5.74 | |
Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Net Inc/Dec In Cash And Cash Equivalents | 11.49 | 39.41 | 33.81 | -25.04 | -0.81 | |
Cash And Cash Equivalents Begin of Year | 77.41 | 38.00 | 4.18 | 29.22 | 3.29 | |
Cash And Cash Equivalents End Of Year | 88.90 | 77.41 | 38.00 | 4.18 | 2.48 |
14.07.2025
Nath Bio-Genes Standalone June 2025 Net Sales at Rs 280.17 crore, up 14.88% Y-o-Y
14.07.2025
Nath Bio-Genes Consolidated June 2025 Net Sales at Rs 283.70 crore, up 16.33% Y-o-Y
02.05.2025
Nath Bio-Genes Consolidated March 2025 Net Sales at Rs 51.97 crore, up 20.75% Y-o-Y
02.05.2025
Nath Bio-Genes Standalone March 2025 Net Sales at Rs 49.37 crore, up 14.71% Y-o-Y
14.07.2025
Nath Bio-Genes Standalone June 2025 Net Sales at Rs 280.17 crore, up 14.88% Y-o-Y
14.07.2025
Nath Bio-Genes Consolidated June 2025 Net Sales at Rs 283.70 crore, up 16.33% Y-o-Y
02.05.2025
Nath Bio-Genes Consolidated March 2025 Net Sales at Rs 51.97 crore, up 20.75% Y-o-Y
02.05.2025
Nath Bio-Genes Standalone March 2025 Net Sales at Rs 49.37 crore, up 14.71% Y-o-Y